Company: ARWR
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0001628280-25-038858
Chunk: 18

Company: ARROWHEAD PHARMACEUTICALS, INC.
Filing Date: 2025-08-07
Form: 10-Q
Item: Part I, Item 1
Chunk 18
---
 interest expense on credit facility48,774 — Changes in operating assets and liabilities:Accounts receivable(9,841)— Prepaid expenses and other assets(22,342)(1,746)Accounts payable21,662 2,785 Accrued expenses7,956 13,086 Deferred revenue22,979 (866)Operating lease, net(3,417)3,880 Other3,128 — Net cash provided by (used in) operating activities159,061 (325,635)CASH FLOWS FROM INVESTING ACTIVITIES:Purchases of property and equipment(15,177)(117,180)Purchases of investments(774,616)(428,611)Proceeds from sales and maturities of investments587,880 348,642 Net cash used in investing activities(201,913)(197,149)CASH FLOWS FROM FINANCING ACTIVITIES:Proceeds from the exercises of stock options3,476 2,166 Proceeds from the issuance of common stock, net of offering costs— 429,265 Proceeds from the sales of future royalties— 50,000 Proceeds from the issuance of warrants25,000 — Payments of debt issuance costs(5,000)— Proceeds from the issuance of common stock241,388 — Repayments of credit facility(201,625)— Proceeds from Visirna credit agreement7,098 — Net cash provided by financing activities70,337 481,431 Net increase (decrease) in cash, cash equivalents and restricted cash27,485 (41,353)Effect of exchange rate on cash, cash equivalents and restricted cash(377)(139)CASH, CASH EQUIVALENTS AND RESTRICTED CASH:BEGINNING OF PERIOD102,685 110,891 END OF PERIOD$129,793 $69,399 Supplementary disclosure of cash flows:Interest paid$(19)$— Income taxes paid$(81)$(3,062)Supplemental disclosure of non-cash investing activities:Capital expenditures included in accrued expenses$346 $6,909 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

4

Arrowhead Pharmaceuticals, Inc.

Notes to Consolidated Financial Statements 

(unaudited)

NOTE 1. ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES

General